These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 36093804)
21. Transplantation of differentiated umbilical cord mesenchymal cells under kidney capsule for control of type I diabetes in rat. Moshrefi M; Yari N; Nabipour F; Bazrafshani MR; Nematollahi-mahani SN Tissue Cell; 2015 Aug; 47(4):395-405. PubMed ID: 26025422 [TBL] [Abstract][Full Text] [Related]
22. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors. Bhonde RR; Sheshadri P; Sharma S; Kumar A Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096 [TBL] [Abstract][Full Text] [Related]
32. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Sun Y; Chen L; Hou XG; Hou WK; Dong JJ; Sun L; Tang KX; Wang B; Song J; Li H; Wang KX Chin Med J (Engl); 2007 May; 120(9):771-6. PubMed ID: 17531117 [TBL] [Abstract][Full Text] [Related]
33. Notch signaling: a novel regulating differentiation mechanism of human umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells in vitro. Hu YH; Wu DQ; Gao F; Li GD; Zhang XC Chin Med J (Engl); 2010 Mar; 123(5):606-14. PubMed ID: 20367990 [TBL] [Abstract][Full Text] [Related]
34. Comparison between the therapeutic effects of differentiated and undifferentiated Wharton's jelly mesenchymal stem cells in rats with streptozotocin-induced diabetes. Hsiao CY; Chen TH; Huang BS; Chen PH; Su CH; Shyu JF; Tsai PJ World J Stem Cells; 2020 Feb; 12(2):139-151. PubMed ID: 32184938 [TBL] [Abstract][Full Text] [Related]
35. Insulin producing cells established using non-integrated lentiviral vector harboring PDX1 gene. Boroujeni ZN; Aleyasin A World J Stem Cells; 2013 Oct; 5(4):217-28. PubMed ID: 24179609 [TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus. Domouky AM; Hegab AS; Al-Shahat A; Raafat N Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600 [TBL] [Abstract][Full Text] [Related]
37. Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation. Kim SJ; Choi YS; Ko ES; Lim SM; Lee CW; Kim DI J Biosci Bioeng; 2012 Jun; 113(6):771-7. PubMed ID: 22425523 [TBL] [Abstract][Full Text] [Related]
38. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs. Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730 [TBL] [Abstract][Full Text] [Related]
39. MafA Overexpression: A New Efficient Protocol for In Vitro Differentiation of Adipose-Derived Mesenchymal Stem Cells into Functional Insulin-Producing Cells. Dayer D; Tabandeh MR; Moghimipour E; Hashemi Tabar M; Ghadiri A; Allah Bakhshi E; Orazizadeh M; Ghafari MA Cell J; 2019 Jul; 21(2):169-178. PubMed ID: 30825290 [TBL] [Abstract][Full Text] [Related]
40. Generation of insulin-producing cells from C3H10T1/2 mesenchymal progenitor cells. Jian RL; Mao LB; Xu Y; Li XF; Wang FP; Luo XG; Zhou H; He HP; Wang N; Zhang TC Gene; 2015 May; 562(1):107-16. PubMed ID: 25724395 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]